Clinical benefits and considerations

For suitable patients, Wegovy tablets offers a convenient alternative to weekly injections and may help achieve clinically meaningful weight loss and improvements in obesity-related health conditions. As with all medicines, these benefits need to be balanced against potential side effects, including nausea, vomiting, diarrhoea, constipation and abdominal discomfort.

People considering switching from injectable Wegovy to the tablet formulation should discuss this with their healthcare professional. The two formulations have different dosing schedules and administration requirements, and a switch should be guided by individual preference, treatment response and medical history.

The role of lifestyle support

It's important to remember that Wegovy is not a replacement for healthy eating, regular physical activity and wider lifestyle support. The medication can be highly effective at supporting weight loss, but long-term success depends on sustainable lifestyle changes. Without maintaining healthy eating patterns and regular physical activity, many people are likely to regain some or all of the lost weight when treatment ends. 

Safety, monitoring and risks

Before starting treatment, patients should ensure their clinician is aware of any existing medical conditions and all medicines they are taking. Particular care may be needed in people with a history of pancreatitis, other significant gastrointestinal disorders, gallstones or other conditions of gallbladder.  Patients should also tell their healthcare professional about any medicines they are taking. 

Medicines that may require particular monitoring or precaution include, but are not limited to, oral anticoagulants such as warfarin, levothyroxine, certain oral antibiotics, some immunosuppressants and antiepileptic medicines, as semaglutide can delay stomach emptying and may affect the efficacy of some oral medications. Additional caution may also be required with some enteric-coated and modified-release medications, where Wegovy mediated altered gut transit may influence drug absorption.

As demand for these medicines increases, people should be wary of counterfeit products being sold online. There have been reports of serious harms associated with fake versions of weight-loss medications, highlighting the risks of purchasing from unregulated sources. People should only obtain Wegovy through legitimate UK prescribing services and registered pharmacies, following consultation with their GP, specialist clinician or a licensed pharmacist. Buying medicines from unofficial sources can put your health at serious risk.

In conclusion

This development represents an important expansion of evidence-based obesity treatment options. Greater choice can improve patient engagement and adherence, but the tablet should not be viewed as a “quick fix”. Careful patient selection, monitoring of side effects, attention to potential drug interactions and continued emphasis on lifestyle modification remain essential for achieving safe and sustainable outcomes.